Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_assertion type Assertion NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_head.
- NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_assertion description "[Further, we document here the efficacy of leptin replenishment in vivo, especially by supplying it to the hypothalamus with the aid of gene therapy, in preventing the antecedent pathophysiological sequalae--hyperinsulinemia, insulin resistance and hyperglycemia--in various animal models and clinical paradigms of diabetes type 1 and 2 with or without attendant obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_provenance.
- NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_assertion evidence source_evidence_literature NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_provenance.
- NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_assertion SIO_000772 19647774 NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_provenance.
- NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_assertion wasDerivedFrom befree-20140225 NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_provenance.
- NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_assertion wasGeneratedBy ECO_0000203 NP174257.RAuDR83jUYovrA2mv5nxX10bj9ZU3Xg23I35tbv-G9Wog130_provenance.